QYUNS-B 02509Hong Kong Stock Exchange

17.0000.00%( +0.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
QYUNS-B (02509) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2024-03-20
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000069W9

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)946.30M55/112
Net Profit (Last FY)368.74M31/125
ROE (Last FY)45.31%2/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
裘霁宛 Executive Director
吴亦亮 Executive Director
林伟栋 Executive Director
余熹 Non-Executive Director
吴志强 Non-Executive Director
冯志伟 Independent Non-Executive Director
邹忠梅 Independent Non-Executive Director
凌建群 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-08-15.

About this page

This page shows QYUNS-B (02509) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.